Intestinal colonization of carbapenem-resistant gram-negative bacteria in pediatric hematology patients: risk factors

Huangdu Hu1, Weiyi Huang2,3,4, Shuwei Ruan5

  • 1Department of Infectious Diseases, Center of General Practice Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.

BMC Microbiology
|December 17, 2025
PubMed

Insights

Carbapenem-resistant gram-negative bacteria (CR-GNB) intestinal colonization affects 13.3% of pediatric hematology patients in China. Younger age, leukemia, lymphoma, and stem cell transplant increase risk, necessitating tailored infection control for this vulnerable group.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatric Hematology

Background:

  • Carbapenem-resistant gram-negative bacteria (CR-GNB) pose a significant threat in healthcare settings.
  • Understanding CR-GNB colonization in immunocompromised pediatric populations is crucial for infection control.
  • Previous studies have not comprehensively assessed CR-GNB intestinal colonization in Chinese pediatric hematology patients.

Purpose of the Study:

  • To determine the prevalence of intestinal CR-GNB colonization in pediatric hematology inpatients across China.
  • To identify risk factors associated with CR-GNB colonization in this patient group.
  • To characterize the molecular features, including resistance mechanisms and genetic profiles, of colonizing CR-GNB isolates.

Main Methods:

  • A multicenter case-control study involving 412 pediatric inpatients with hematological diseases.
  • Screening for CR-GNB intestinal colonization, followed by antimicrobial susceptibility testing and whole-genome sequencing of isolates.
  • Logistic regression analysis to identify risk factors and comparative analysis with adult patients.

Main Results:

  • A prevalence of 13.3% for CR-GNB intestinal colonization was observed, with carbapenem-resistant Enterobacterales (CRE) being most common.
  • Independent risk factors included younger age, acute leukemia, lymphoma, and hematopoietic stem cell transplantation (HSCT).
  • Molecular analysis revealed NDM enzyme prevalence in specific species, while carbapenem-resistant Klebsiella pneumoniae (CRKP) showed non-carbapenemase-producing resistance mechanisms; pediatric CRE isolates had lower resistance to aminoglycosides and beta-lactamase inhibitor combinations compared to adults.

Conclusions:

  • CR-GNB colonization represents a substantial burden with significant molecular diversity in pediatric hematology patients in China.
  • Findings highlight the need for pediatric-specific surveillance and infection control strategies.
  • Strategies should address species-specific resistance patterns and unique clinical vulnerabilities of this population.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174